This diagnostic method, which is nationally rare and uniquely available in private care, is offered exclusively at the Újszeged Health Center Diabetes Center! For more details:
CLICK HERE
Diabetic nerve damage (neuropathy) accounts for one-third of all neuropathies and is often the first indication of diabetes. Typical symptoms of nerve damage include a reduction or complete loss of sensations such as heat, pain, vibration, or touch. As a result, patients may not notice wounds or ulcers forming on their feet. Common complaints include unsteady gait, numbness, or tingling in the legs. These symptoms are typically irreversible, making early detection of diabetes and neuropathy essential.
One simple and painless method for this is the Neurometer test, which can be performed at the Újszeged Diabetes Center in about 30 minutes by prior appointment. If abnormalities are detected, both diabetologists and neurologists can recommend subsidized medications to alleviate the symptoms.
The Neurometer is a diagnostic device capable of simultaneously evaluating all three types of sensory nerve fibers with specific and quantifiable results. The test is based on determining the threshold for electrical sensation through the skin. The current is gradually increased until the patient perceives the impulse, then decreased until no sensation or tingling is felt.
The examination is performed on both the upper and lower extremities across three frequencies (2 kHz, 250 Hz, 5 Hz).
Values above the normal range indicate delayed sensation, signaling impaired nerve function, while values below the normal range suggest hypersensitivity. The Neurometer also provides a quantitative assessment of thin, unmyelinated nerve fibers that mediate pain perception.
We are placing greater emphasis on screening for nerve damage because recent scientific findings indicate that patients with even asymptomatic neuropathy are at higher risk for other cardiovascular complications. These findings are supported by the internationally recognized research conducted by the Diabetes Center’s clinical diabetologists. Their work has been published in scientific journals, presented at conferences, and even included in book publications.
This cutting-edge knowledge allows for early identification of patients with neuropathy who may be referred for further examinations (e.g., cardiovascular reflex tests for additional risk screening) or ongoing cardiological, neurological, or nephrological care, helping to prevent fatal outcomes.